One of the most important goals considered in the research for the treatment of allergic respiratory diseases and asthma, is the specific suppression of inflammatory mediators to change Th2 responses to Th1 by increasing the secretion of interferon gamma (INF-γ), IL-12 and tumor necrosis factor-β (TNF-β). The gene discussed is IFNG; the disease is asthma.